Dental Care Clinics in River Oaks, TX Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 River Oaks Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 901 Roberts Cutoff Rd, River Oaks, TX 76114 Phone: 817-738-4141 |
West Texas Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 5422 River Oaks Blvd, River Oaks, TX 76114 Phone: 716-984-8585 |
Smiley Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4843 River Oaks Blvd, River Oaks, TX 76114 Phone: 214-718-7880 |
Signature Family Dentistry Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4839 River Oaks Blvd., River Oaks, TX 76114 Phone: 469-387-6853 |
News Archive
First comprehensive center opened in Tri-State area to mark new era in care of DMD patients
Nearly 1,000 boys in the New York Tri-State area have been diagnosed with Duchenne Muscular Dystrophy (DMD) and, until now, had to travel out of the state for comprehensive care.
MIT device to detect and prevent epileptic seizures
Epilepsy affects about 50 million people worldwide, and while anticonvulsant medications can reduce the frequency of seizures, the drugs are ineffective for as many as one in three patients.
TJP1 protein could help determine multiple myeloma patients who may best benefit from proteasome inhibitors
A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by The University of Texas MD Anderson Cancer Center.
Vitamin Angels and Walgreens provide 100 million children and mothers with essential vitamins, minerals
As part of its purpose to help people get, stay and live well, Walgreens (NYSE: WAG) (NASDAQ: WAG) is extending its exclusive relationship with Vitamin Angels to help provide 100 million children and mothers in at-risk populations with essential vitamins and minerals.
Sequential treatment with Entecavir and Lamivudine results in rebound of hepatitis B virus
A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases..
› Verified 8 days ago